MGX
Metagenomi, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$47.06M
P/E Ratio
—
EPS
$-2.29
Beta
0.65
52W High
$3.95
52W Low
$1.20
50-Day MA
$1.37
200-Day MA
$1.76
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Metagenomi, Inc. Common Stock
Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company is headquartered in Emeryville, California.
Fundamentals
| Revenue (TTM) | $22.33M |
| Gross Profit (TTM) | $-72.10M |
| EBITDA | $-87.55M |
| Operating Margin | -1970.00% |
| Return on Equity | -49.00% |
| Return on Assets | -23.40% |
| Revenue/Share (TTM) | $0.60 |
| Book Value | $3.66 |
| Price-to-Book | 0.34 |
| Price-to-Sales (TTM) | 2.11 |
| EV/Revenue | 0.712 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -69.80% |
| Shares Outstanding | $37.65M |
| Float | $27.35M |
| % Insiders | 18.96% |
| % Institutions | 19.32% |
Historical Volatility
HV 10-Day
40.26%
HV 20-Day
41.82%
HV 30-Day
38.03%
HV 60-Day
41.88%
HV Rank
1.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.00 target)
4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026